Icon

AZOPT (nda020816)- (1%)

BRINZOLAMIDE SANDOZ
1%
No No
2013-Apr-24 Expired
None None
None No
AZOPT is a carbonic anhydrase inhibitor indicated for in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma
3 0 3
Total Other Developers 30
Drugs with Suitability No
1% ** ** Down - 3
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** **** ****** & **** ************ *********** **** ****** ***** *******, *****, ******* (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.